BRIEF-Ascletis Pharma Updates On Investigational New Drug Approval

Aug 28 (Reuters) - Ascletis Pharma Inc:

* CO & SAGIMET BIOSCIENCES RECEIVED INVESTIGATIONAL NEW DRUG APPROVAL FOR ASC40 FROM CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION Source text for Eikon: Further company coverage: